| Title |
Year |
Author |
Number |
| AMORPHOUS FORM OF N-{2-FLUORINE-5-[3-(THIOPHEN-2-CARBONYL)-PIRAZOLO[1,5-a]-PYRIMIDIN-7-YL]-PHENYL)-N-METHYL-ACETAMIDE, METHOD FOR PREPARING IT, PHARMACEUTICAL COMPOSITION (VERSIONS) CONTAINING SAID AMORPHOUS FORM AND DRUG AND METHOD OF TREATING AND/OR PREVENTING NERVOUS DISORDERS |
2007 |
- Anglada Luis
- Gul'Etta Antonio
- Palomer Al'Bert
|
RU2450005C2 |
| POLYMORPHIC MODIFICATION IN N-{5-[3-(THIOPHENE-2-CARBONYL)-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL]-2-FLUORO-PHENYL}-N-METHYL-ACETAMIDE (VERSIONS), CONTAINING IT PHARMACEUTICAL COMPOSITION (VERSIONS), MEDICATION, METHOD OF OBTAINING SAID POLYMORPHIC MODIFICATION (VERSIONS) AND METHOD OF TREATMENT AND/OR PREVENTION OF NERVOUS DISORDERS |
2007 |
- Anglada Luis
- Gul'Etta Antonio
- Palomer Al'Bert
|
RU2413729C2 |
| DERIVATIVES OF 7-[3-[4-(6-FLUOROBENZO[D]ISOXAZOL-3-YL)-PIPERIDINE-1-YL]PROPOXY]- CHROMEN-4-ONE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION FOR INHIBITION OF D-, 5-HT- AND H-RECEPTORS AND METHOD OF INHIBITION OF D-, 5-HT- AND H-RECEPTORS IN TREATMENT OF PSYCHOSIS AND SCHIZOPHRENIA |
1998 |
- Bolos Khordi
- Kastello Khosep M.
- Ortis Khose A.
- Sakristan Aurelio
- Foget Rafaehl'
|
RU2179556C2 |
| SERTACONASOLE MONONITRATE PROCESS AND SERTACONASOLE MONONITRATE MONOHYDRATE |
2005 |
- Kamps Ksav'Er
- Petschen Ines
- Sal'Jares Khuan
|
RU2357965C2 |
| POLYMORPHOUS MODIFICATION II OF ANTIFUNGAL COMPOUND, METHOD FOR PREPARING IT (VERSIONS), BASED PHARMACEUTICAL AND AGRICULTURAL COMPOSITION, METHOD OF TREATING OR PREVENTING DISEASES CASED BY FUNGI AND/OR YEAST |
2009 |
- Albet Karles
- Del'Gado Monika
- Petschen Oliv Inehs
- Tarruehlla Marta
|
RU2477280C1 |
| METHOD OF PRODUCING R-(-)- SERTACONAZOLE MONONITRATE AND POLYACETONATE OF R-(-)-SERTACONAZOLE MONONITRATE |
2005 |
- Kamps Ksav'Er
- Petschen Ines
- Sal'Jares Khuan
|
RU2413728C2 |
| HALOGENISED PYRAZOLO[1,5-a]PYRIMIDINES (VERSIONS), METHODS FOR PREPARING THEM, BASED PHARMACEUTICAL COMPOSITION, INTERMEDIATE COMPOUNDS AND METHOD FOR PREPARING THEM (VERSIONS) |
2006 |
- Anglada Luis
- Gul'Etta Antonio
- Palomer Al'Bert
|
RU2478101C2 |
| METHOD OF PRODUCING N-{5-[3-(THIOPHENE-2-CARBONYL)-PYRAZOLE[1,5-a]PYRIMIDIN-7-YL]-2-FLUORO-PHENYL}-N-METHYL-ACETAMIDE IN POLYMORPHIC MODIFICATION B |
2007 |
- Anglada Luis
- Gul'Etta Antonio
- Palomer Al'Bert
|
RU2404984C1 |
| PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITION SHOWING ABILITY TO INHIBIT GABA RECEPTORS, AND DRUG FOR TREATING AND PREVENTING DISORDERS ASSOCIATED WITH GABA RECEPTOR INHIBITION |
2007 |
- Anglada Luis
- Gul'Etta Antonio
- Palomer Al'Bert
|
RU2458063C2 |
| TWO-LAYERED TABLET FOR PREVENTING CARDIOVASCULAR DISTURBANCES, DRUG AND METHOD FOR PREVENTING CARDIOVASCULAR DISTURBANCES, INCLUDING APOPLEXY AND PARALYSIS BY USING SAID TABLET |
2007 |
- Gerrero Marta
- Gul'Etta Antonio
- Orriol'S Anna
|
RU2445088C2 |
; c = 22.79 
; α = β = 90°; γ = 120° and cell unit = 183 
with roentgen diffraction spectrum of the following values d(
): 7.597; 3.798; 2.6202; 2.5698; 2.5322; 2.2830; 1.93545; 1.72447; 1.62930; 1.52289; 1.49318; 1.46002; 1.41351; 1.38528 and 1.31011 with the presence of characteristic bands in its infra-red spectrum at 1361 and 449 см-1 and characterized by DSC-thermogram obtained by DSC method (differential scanning calorimetry), and method of its synthesis. This compound is used in therapy as an antacid agent and gastroprotector. EFFECT: broadened assortment of drugs. 6 cl, 3 dwg, 5 tbl, 4 ex